{
    "status": "ok",
    "totalResults": 12,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "InvestorsObserver"
            },
            "author": "InvestorsObserver",
            "title": "Healthcare Stocks Making Moves Wednesday: VVOS, VTVT, BMEA, DRIO, BIVI, SEEL, EGRX, AXLA",
            "description": "These Healthcare stocks are trading higher:\n-Vivos Therapeutics Inc (VVOS) stock is trading at $17.31, an increase of $12.92, or 297.49%, on high volume.  Vivos Therapeutics Inc",
            "url": "https://www.investorsobserver.com/news/stock-update/healthcare-stocks-making-moves-wednesday-vvos-vtvt-bmea-drio-bivi-seel-egrx-axla",
            "urlToImage": "https://s3.amazonaws.com/images.investorsobserver.com/wp-content/uploads/2019/09/10145424/190910-MedicalDevices.jpg",
            "publishedAt": "2023-11-29T14:20:25Z",
            "content": "These Healthcare stocks are trading higher:\r\n-Vivos Therapeutics Inc (VVOS) stock is trading at $17.31, an increase of $12.92, or 297.49%, on high volume. Vivos Therapeutics Inc gets a Sentiment Scor\u2026 [+1589 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Analyzing Bioventus (NYSE:BVS) and Vivos Therapeutics (NASDAQ:VVOS)",
            "description": "Bioventus (NYSE:BVS \u2013 Get Free Report) and Vivos Therapeutics (NASDAQ:VVOS \u2013 Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendat\u2026",
            "url": "https://www.etfdailynews.com/2023/11/24/analyzing-bioventus-nysebvs-and-vivos-therapeutics-nasdaqvvos/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/vivos-therapeutics-inc-logo.png?v=20210414112348&w=240&h=240&zc=2",
            "publishedAt": "2023-11-24T13:16:29Z",
            "content": "Bioventus (NYSE:BVS \u2013 Get Free Report) and Vivos Therapeutics (NASDAQ:VVOS \u2013 Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies b\u2026 [+5173 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Biztoc.com"
            },
            "author": "globenewswire.com",
            "title": "Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea",
            "description": "LITTLETON, Colo., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the \u201cCompany\u201d or \u201cVivos\u201d) (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatm\u2026",
            "url": "https://biztoc.com/x/ecf1d10a1d481a88",
            "urlToImage": "https://c.biztoc.com/p/ecf1d10a1d481a88/og.webp",
            "publishedAt": "2023-11-29T19:48:12Z",
            "content": "LITTLETON, Colo., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the Company or Vivos) (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and \u2026 [+290 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Biztoc.com"
            },
            "author": "benzinga.com",
            "title": "Why Is Sleep Disorder Device Provider Vivos Therapeutics Stock Trading Higher Today?",
            "description": "Vivos Therapeutics Inc VVOS received FDA 510(k) clearance for treating severe obstructive sleep apnea (OSA) in adults using the Vivos' removable CARE (Complete Airway Repositioning and/or Expansion) oral appliances. Vivos' CARE appliances include the flagship\u2026",
            "url": "https://biztoc.com/x/c563b5f2a0d92c98",
            "urlToImage": "https://c.biztoc.com/p/c563b5f2a0d92c98/s.webp",
            "publishedAt": "2023-11-29T15:38:07Z",
            "content": "Vivos Therapeutics Inc VVOS received FDA 510(k) clearance for treating severe obstructive sleep apnea (OSA) in adults using the Vivos' removable CARE (Complete Airway Repositioning and/or Expansion) \u2026 [+238 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Thinking about buying stock in Minim Inc, Walmart, Farfetch Ltd, Qualcomm, or Vivos Therapeutics Inc?",
            "description": "(marketscreener.com) \n\nNEW YORK, Nov. 30, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MINM, WMT, FTCH, QCOM, and VVOS.\n\n \n \n \n \n \n \n\n \nTo see how InvestorsObserver's proprietary scoring system rates these stocks, view the...ht\u2026",
            "url": "https://www.marketscreener.com/quote/stock/WALMART-INC-4841/news/Thinking-about-buying-stock-in-Minim-Inc-Walmart-Farfetch-Ltd-Qualcomm-or-Vivos-Therapeutics-Inc-45474567/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-11-30T14:32:05Z",
            "content": "NEW YORK, Nov. 30, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MINM, WMT, FTCH, QCOM, and VVOS.\r\nTo see how InvestorsObserver's proprietary scoring system rates these\u2026 [+1552 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Vivos Therapeutics Shares More than Double on FDA's 510(k) Clearance for Sleep Apnea Treatment",
            "description": "(marketscreener.com) \n By Denny Jacob \n\n\n Vivos Therapeutics shares more than doubled following 510 clearance from the U.S. Food and Drug Administration for treating severe obstructive sleep apnea using its oral appliances. \n\n The stock, which rose 169% to $1\u2026",
            "url": "https://www.marketscreener.com/quote/stock/VIVOS-THERAPEUTICS-INC-116418037/news/Vivos-Therapeutics-Shares-More-than-Double-on-FDA-s-510-k-Clearance-for-Sleep-Apnea-Treatment-45463944/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-11-29T15:41:03Z",
            "content": "By Denny Jacob \r\nVivos Therapeutics shares more than doubled following 510(k) clearance from the U.S. Food and Drug Administration for treating severe obstructive sleep apnea using its oral appliance\u2026 [+573 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Sleep Apnea Oral Appliances Market Size Worth USD 1.55 Billion By 2032 | CAGR of 13.2%",
            "description": "The Global Sleep Apnea Oral Appliances Market Size was valued at USD 0.45 Billion in 2022 and the Worldwide Sleep Apnea Oral Appliances Market Size is expected to reach USD 1.55 Billion by 2032, according to a research report published by Spherical Insights &\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/28/2787214/0/en/Global-Sleep-Apnea-Oral-Appliances-Market-Size-Worth-USD-1-55-Billion-By-2032-CAGR-of-13-2.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-11-28T16:30:00Z",
            "content": "New York, United States, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The Global Sleep Apnea Oral Appliances Market Size is to Grow from USD 0.45 Billion in 2022 to USD 1.55 Billion by 2032, at a Compound Annua\u2026 [+9805 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Biztoc.com"
            },
            "author": "marketwatch.com",
            "title": "Vivos Therapeutics\u2019 stock soars as sleep apnea device gets regulatory clearance",
            "description": "Vivos Therapeutics Inc. shares VVOS jumped more than 270% Wednesday after the medical-device maker got regulatory clearance for removable oral appliances that treat obstructive sleep apnea. The U.S. Food and Drug Administration gave a green light for Vivos CA\u2026",
            "url": "https://biztoc.com/x/f68bd27a0ec70577",
            "urlToImage": "https://c.biztoc.com/p/f68bd27a0ec70577/s.webp",
            "publishedAt": "2023-11-29T16:34:08Z",
            "content": "Vivos Therapeutics Inc. shares VVOS jumped more than 270% Wednesday after the medical-device maker got regulatory clearance for removable oral appliances that treat obstructive sleep apnea.The U.S. F\u2026 [+240 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Vivos Therapeutics, Inc",
            "title": "Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea",
            "description": "With this unprecedented FDA clearance, Vivos redefines what it means to have a truly non-invasive treatment for all levels of OSA severity, opening new revenue opportunities for Vivos With this unprecedented FDA clearance, Vivos redefines what it means to hav\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/29/2787639/0/en/Vivos-Therapeutics-Receives-First-Ever-FDA-510-k-Clearance-for-Oral-Device-Treatment-of-Severe-Obstructive-Sleep-Apnea.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/22d07f60-2e17-421d-bbc3-748c2402061e",
            "publishedAt": "2023-11-29T12:30:00Z",
            "content": "LITTLETON, Colo., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the Company or Vivos) (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and \u2026 [+8627 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "InvestorsObserver"
            },
            "author": "InvestorsObserver",
            "title": "Healthcare Stocks Moving Thursday: SNGX, NBSE, IMGN, AMPE, VVOS, RDHL, MOTS, ARWR",
            "description": "These Healthcare stocks are trading higher:\n-Soligenix, Inc. Common Stock (SNGX) stock is trading at $1.31, an increase of $0.89, or 213.38%, on high volume.  Soligenix Inc gets",
            "url": "https://www.investorsobserver.com/news/stock-update/healthcare-stocks-moving-thursday-sngx-nbse-imgn-ampe-vvos-rdhl-mots-arwr",
            "urlToImage": "https://s3.amazonaws.com/images.investorsobserver.com/wp-content/uploads/2020/08/07100900/Soft-Gelatin-Capsules.jpg",
            "publishedAt": "2023-11-30T14:16:55Z",
            "content": "These Healthcare stocks are trading higher:\r\n-Soligenix, Inc. Common Stock (SNGX) stock is trading at $1.31, an increase of $0.89, or 213.38%, on high volume. Soligenix Inc gets a Sentiment Score of \u2026 [+1965 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Vivos Therapeutics, Inc",
            "title": "Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call",
            "description": "Call Scheduled for Tuesday, November 14, 2023 at 5:00 pm ET Call Scheduled for Tuesday, November 14, 2023 at 5:00 pm ET",
            "url": "https://www.globenewswire.com/news-release/2023/11/09/2777907/0/en/Vivos-Therapeutics-Schedules-Release-of-Third-Quarter-2023-Financial-Results-and-Conference-Call.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/22d07f60-2e17-421d-bbc3-748c2402061e",
            "publishedAt": "2023-11-09T21:30:00Z",
            "content": "LITTLETON, Colo., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (Vivos or the Company) (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patien\u2026 [+4070 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "MarketWatch"
            },
            "author": "Eleanor Laise",
            "title": "Vivos Therapeutics\u2019 stock soars as sleep apnea device gets regulatory clearance",
            "description": "Vivos Therapeutics jumped more than 270% after the FDA cleared the company's devices for severe sleep apnea.",
            "url": "https://www.marketwatch.com/story/vivos-therapeutics-stock-soars-as-sleep-apnea-device-gets-regulatory-clearance-633c54da",
            "urlToImage": "https://images.mktw.net/im-850238/social",
            "publishedAt": "2023-11-29T16:09:00Z",
            "content": "Vivos Therapeutics Inc. shares VVOS jumped more than 270% Wednesday after the medical-device maker got regulatory clearance for removable oral appliances that treat obstructive sleep apnea. \r\nThe U.S\u2026 [+287 chars]"
        }
    ]
}